Medications for Hemophilia A

5 results
  • afstyla

    (Antihemophilic Factor, Human Recombinant)
    Csl Behring Lengnau Ag
    Afstyla treats adults and children with hemophilia A (congenital Factor VIII deficiency) for on-demand bleeding control, routine prophylaxis to reduce bleeding frequency, and perioperative bleeding management. Not indicated for von Willebrand disease.
  • altuviiio - antihemophilic factor

    (Antihemophilic Factor (Recombinant), Fc-Vwf-Xten Fusion Protein-Ehtl)
    Bioverativ Therapeutics Inc.
    ALTUVIIIO is indicated for adults and pediatric patients with hemophilia A (congenital factor VIII deficiency) for routine prophylaxis to reduce bleeding episodes, on-demand treatment and control of bleeding, and perioperative bleeding management. Not indicated for von Willebrand disease.
  • eloctate

    (Antihemophilic Factor (Recombinant), Fc Fusion Protein)
    Bioverativ Therapeutics Inc.
    Eloctate is indicated for adults and children with Hemophilia A (congenital Factor VIII deficiency) for on-demand treatment and control of bleeding episodes, perioperative bleeding management, and routine prophylaxis to reduce bleeding frequency. Not indicated for von Willebrand disease.
  • hympavzi - marstacimab - hncq injection, solution

    (Marstacimab-Hncq)
    Pfizer Laboratories Div Pfizer Inc
    HYMPAVZI is used for routine prophylaxis to prevent or reduce bleeding episodes in patients 12 and older with hemophilia A (without factor VIII inhibitors) or hemophilia B (without factor IX inhibitors).
  • xyntha

    (Antihemophilic Factor (Recombinant))
    Wyeth Biopharma Division Of Wyeth Pharmaceuticals Llc
    Xyntha is indicated for adults and children with hemophilia A (congenital factor VIII deficiency) for on-demand treatment and control of bleeding episodes, perioperative management, and routine prophylaxis to reduce bleeding frequency. Not indicated for von Willebrand's disease.